可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Griese DP, Achatz S, Batzlsperger CA, et al. Vascular gene delivery of anticoagulants by transplantation of retrovirallytransduced endothelial progenitor cells[J]. Cardiovasc Res, 2003,58(2):469-477.
[2]Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk[J]. N Engl J Med, 2003,348(7):593-600.
[3]Werner N, Junk S, Laufs U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury[J]. Circ Res, 2003,93(2):e17-e24.
[4]中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 不稳定性心绞痛诊断和治疗建议[J]. 中华心血管病杂志, 2000,28(6): 409-412.
[5]Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease[J]. Circ Res, 2001,89(1):e1-e7.
[6]Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization[J]. Proc Natl Acad Sci U S A, 2000,97(7):3422-3427.
[7]Suzuki T, Nishida M, Futami S, et al. Neoendothelialization after peripheral blood stem cell transplantation in humans: a case report of a Tokaimura nuclear accident victim[J]. Cardiovasc Res, 2003,58(2):487-492.
[8]Murayama T, Tepper OM, Silver M, et al. Determination of bone marrowderived endothelial progenitor cell significance in angiogenic growth factorinduced neovascularization in vivo[J]. Exp Hematol, 2002,30(8):967-972.